Experience

Innovacell Biotechnologie AG v. University of Pittsburgh*

Innovacell Biotechnologie AG

University of Pittsburgh

Represented Innovacell in opposition related to the use of myoblasts for treating the urinary sphincter muscle.

Innovacell Biotechnologie AG v. University of Pittsburgh, T 1031/16, EPO

Related Practices

Patent Office Invalidation Proceedings

Patent Oppositions and Appeals

Related Industries

Life Sciences

Biotechnology

*Matter handled prior to joining Finnegan

Related Experiences

Innovacell Biotechnologie AG v. University of Pittsburgh*

Innovacell Biotechnologie AG

Innovacell AG v. University of Pittsburgh*

Innovacell AG

Academisch Ziekenhuis Leiden v. University of Western Australia

University of Western Australia

Medinol v. Abbott

Abbott

University of Florida Research Foundation, Inc. v. Koninklijke Philips NV

Koninklijke Philips NV

Hyundai Electronics v. Siemens AG

Hyundai Electronics

Pfizer Inc. v. Bayer AG

GlaxoSmithKline

Represented a medical devices company before German Civil Courts and the European Patent Office (EPO)*

Certain Dynamic Random Access Memory Semiconductors 

Elpida Memory, Inc. et. al.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.